An additional alternative is CD34+ cell boost, which shows encouraging results, but is limited by donor availability, the need to mobilize, extract, and isolate donor cells, and some risk of GvHD associated with the presence of CD3+ cells. Here, CD34 is linked to graft versus host disease.